DiBAC4(3) acts as a potent activator of arterial BK channels independently of the β1-subunit, revealing gating mechanisms that may aid in the rational design of future BK channel activators.
No takes yet. Share an insight, caveat, or question.
May guide β1-independent BK activator design; leaves open translation to human arterial therapy.
Scornik et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: